Matthew Kelsey
Stock Analyst at HC Wainwright & Co.
(0.16)
# 4,187
Out of 4,855 analysts
7
Total ratings
25%
Success rate
-24.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Kelsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNSE Sensei Biotherapeutics | Assumes: Buy | $5 | $0.34 | +1,352.64% | 1 | Jun 2, 2025 | |
| ACXP Acurx Pharmaceuticals | Assumes: Buy | $8 | $0.35 | +2,205.48% | 1 | May 15, 2025 | |
| DBVT DBV Technologies | Maintains: Equal-Weight | $260 → $100 | $9.13 | +995.29% | 5 | Dec 20, 2018 |
Sensei Biotherapeutics
Jun 2, 2025
Assumes: Buy
Price Target: $5
Current: $0.34
Upside: +1,352.64%
Acurx Pharmaceuticals
May 15, 2025
Assumes: Buy
Price Target: $8
Current: $0.35
Upside: +2,205.48%
DBV Technologies
Dec 20, 2018
Maintains: Equal-Weight
Price Target: $260 → $100
Current: $9.13
Upside: +995.29%